Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1141.97
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 22 EP applications Graham Matthew Lewis has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12775575

MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Graham Matthew Lewis, J A Kemp
Status:
PATENT GRANTED
EP12780408

PD-L1 BASED IMMUNOTHERAPY

IPC classification:
A61K 39/00, A61P 35/00, C07K 14/705
Applicant:
Herlev Hospital
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Høiberg A/S
Status:
EXAMINATION IN PROGRESS
EP13701871

COMBINED THERAPEUTIC USE OF ANTIBODIES AND ENDOGLYCOSIDASES

IPC classification:
A61K 39/395, C07K 16/32, C12N 9/24
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14194371

Methods for PCR-based detection of "ultra short" nucleic acid sequences

IPC classification:
C12Q 1/68
Agent:
Graham Matthew Lewis, J A Kemp
Status:
PATENT GRANTED
EP14196121

Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers

IPC classification:
A61K 31/337, A61K 31/517, A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/32
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13848584

STABLE, LOW VISCOSITY ANTIBODY FORMULATION

IPC classification:
A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP15157213

Induced activation in dendritic cells

IPC classification:
A61K 38/00, A61K 48/00, C12N 15/74
Applicant:
Baylor College of Medicine
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP13814593

VACCINES AGAINST HEPATITIS B VIRUS

IPC classification:
A61K 39/12, A61K 39/29, A61P 35/00, C07K 14/02, C12N 7/00
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15170905

IDES, AN IGG-DEGRADING ENZYME OF STREPTOCOCCUS PYOGENES

IPC classification:
A61K 38/43, A61K 39/09, C07K 14/81, C07K 16/40, C12N 5/10, C12N 9/52, C12N 15/57, G01N 33/50, G01N 33/68
Applicant:
Hansa Medical AB
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP15172571

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14764564

METHODS OF MAKING CANCER COMPOSITIONS

IPC classification:
A01N 57/00
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP14762073

ONCOLOGY VACCINE

IPC classification:
A61K 38/16, A61K 39/00, A61P 35/00
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14842266

HPV DETECTION IN URINE

IPC classification:
C12Q 1/04, C12Q 1/68
Agent:
Graham Matthew Lewis, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14843312

PREDICTING BREAST CANCER RECURRENCE

IPC classification:
C12Q 1/68
Agent:
Graham Matthew Lewis, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14772310

A METHOD FOR ANALYSING A SAMPLE OF IMMUNOGLOBULIN MOLECULES

IPC classification:
C12N 9/00, G01N 33/68
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15200538

PEPTIDES FOR VACCINE AGAINST BIRCH ALLERGY

IPC classification:
A61K 39/36
Applicant:
Circassia Limited
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP14853533

DETECTING MUTATIONS IN DISEASE OVER TIME

IPC classification:
C12Q 1/68
Agent:
Graham Matthew Lewis, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP16173573

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF

IPC classification:
A61K 39/395, C07K 14/71, C07K 16/28
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15786799

METHOD FOR DIAGNOSING AND MONITORING THE PRESENCE OF CANCER IN A HUMAN SUBJECT

IPC classification:
A61K 31/445, A61K 39/00, A61P 35/00, G01N 33/574
Applicant:
Servicio Andaluz de Salud
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP15782849

CONCENTRATING NUCLEIC ACIDS IN URINE

IPC classification:
C12M 1/12, C12N 15/10, C12P 19/34
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP15832111

CANCER DIAGNOSIS AND THERAPY

IPC classification:
A61B 5/00, A61K 31/138, A61K 31/40, A61P 35/00, G01N 33/574
Agent:
Graham Matthew Lewis, J A Kemp
Status:
EXAMINATION REQUESTED
EP15861991

METHOD OF MAKING PRODRUGS AND TARGETED THERAPEUTIC COMPOUNDS

IPC classification:
C07K 7/06, G01N 33/574
Agent:
Graham Matthew Lewis, J A Kemp
Status:
Request for examination was made

Please Sign in to use this feature